1Topf N,Worgall S,Hackett NR,et al."Pro-drug"gene therapy:intravenous administration of an adenoviral vector expressioning the E.coli cytosine deaminase gene and systemic administration of 5-fluorocytosine suppresses growth of hepatic metastasis of colon carcinoma[J].Gene Ther,1998,5(4):507-513.
2Gnant MF,Puhlmann M,Bartlett DL,et al.Regional versus systemic delivery of recombinant vaccinia virus as suicide gene therapy for murine liver metastases[J].Ann Surg,1999,230(3):352-360.
3Li H,Griscelli F,Lindenmeyer F,et al.Systemic delivery of antiangiogenic adenovirus Adm ATF induces liver resistance to metastasis and prolongs survival of mice[J].Human Gene Ther,1999,10(18):3045-3053.
4Nishikawa M,Yamauchi M,Morimoto K,et al.Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multifunctional gene delivery system[J].Gene Ther,2000,7 (7):548-555.
6Anderson SC,Johnson DE,harris Mp,et al.P53 gene therapy in a rat model of hepatocellular carcinoma:intra-arterial delivery of a recombinant adenoviraus[J].Clin Cancer Res,1998,4(7):1649-1659.
7Pietersen AM,van der Eb MM,Rademaker HJ,et al.Specific tumor -cell killing with adenoviraus vectors containing the apoptin gene[J].Gene Ther,1999,6(5):882-892.
8Hall FL,Liu L,Zhu NL,et al.Molecular engineering of matrix-targeted retroviral vectors incorporating a surveillance function inherent in von Wille brand factor[J].Human Gene Ther,2000,11(7):983-993.
9Hurford RK Jr,Dranoff G,Mulligan RC,et al.Gene therapy of metastatic cancer by in vivo retroviral gene targeting[J].Nat Genet,1995,10(4):430-435.
